How much does the targeted drug Bimetinib cost?

Binimetinib (Binimetinib) is used with encorafenib (canafenib; Braftovi) to treat certain types of melanoma (a type of skin cancer) that have spread to other parts of the body or cannot be removed with surgery. It can also be used to treat adult patients with BRAF V600E mutated metastatic non-small cell lung cancer. Bimetinib belongs to the kinase inhibitor class of drugs. It works by blocking the activity of abnormal proteins, which are signals for cancer cell reproduction, which helps prevent or slow down the spread of cancer cells.

Bimetinib is available as an oral tablet. It is usually taken twice a day, about 12 hours apart, with or without food. Take bimetinib at about the same time each day, exactly as directed, and do not take more or less than your doctor recommends. If you vomit after taking the medicine, do not take any more medicine. Continue regular dosing schedule. Depending on whether the patient experiences any side effects, doctors may reduce or temporarily or permanently stop treatment with bimetinib. If the patient is breast-feeding, tell the doctor not to breastfeed while taking bimetinib and for 3 days after the last dose.

The original drug bimetinib has not yet been launched in China, and therefore is not covered by medical insurance. Bimetiniboriginal drug sold overseas, specifications15mg*84 tablets may cost more than 10,000 yuan per box (the price may fluctuate due to exchange rates), which is relatively expensive. There is currently no generic drug of Bimetinib produced and launched. For more drug information and specific prices, please consult a medical consultant.